SCHEMBL21074203

SCHEMBL21074203

N#Cc1nc(-c2ccc(N3c4ccccc4Cc4ccccc43)cc2)c(-c2ccc(N3c4ccccc4Cc4ccccc43)cc2)nc1C#N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.40
USP8 P40818 2/20 0.36
USP7 Q93009 1/20 0.36
USP47 Q96K76 1/20 0.36
MAPKAPK2 P49137 1/20 0.34
CHEK1 O14757 1/20 0.34
ABL1 P00519 1/20 0.34
PDGFRB P09619 1/20 0.34
PDGFRA P16234 1/20 0.34
FLT1 P17948 1/20 0.34
GRK5 P34947 1/20 0.34
KDR P35968 1/20 0.34
MAP2K2 P36507 1/20 0.34
CDK8 P49336 1/20 0.34
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
PRKX P51817 1/20 0.34
NEK2 P51955 1/20 0.34
LIMK1 P53667 1/20 0.34
MAP2K1 Q02750 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21074085 0.94 HPGD (0.40) HPGDUSP8USP7USP47MAPKAPK2
SCHEMBL21074243 0.85 CHEK1 (0.41) HPGDUSP8USP7USP47CHEK1
SCHEMBL23837148 0.82
SCHEMBL26413984 0.80 ADORA1 (0.50) HPGDALDH1A1HTTKDM4ERXFP1
SCHEMBL21074242 0.80 HDAC6 (0.43) USP8USP7USP47CHEK1ABL1
SCHEMBL29437709 0.80 CHEK1 (0.37) HPGDUSP8USP7USP47CHEK1
SCHEMBL21074161 0.80 CHEK1 (0.37) HPGDUSP8USP7USP47CHEK1
SCHEMBL23839151 0.80
SCHEMBL19345021 0.79 HPGD (0.44) HPGDKDM4ETSHRPOLB
SCHEMBL21074089 0.79 CHEK1 (0.44) HPGDUSP8USP7USP47CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10399960-B2 Dicyanopyrazine compound, luminescent material, luminescence device using the same, and method for producing 2,5-dicyano-3,6-dihalogenopyrazine KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2019-09-03 US disclosed
US-20190229274-A1 DICYANOPYRAZINE COMPOUND, LUMINESCENT MATERIAL, LUMINESCENCE DEVICE USING THE SAME, AND METHOD FOR PRODUCING 2,5-DICYANO-3,6-DIHALOGENOPYRAZINE KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2019-07-25 US disclosed
US-20190169170-A1 DICYANOPYRAZINE COMPOUND, LUMINESCENT MATERIAL, LUMINESCENCE DEVICE USING THE SAME, AND METHOD FOR PRODUCING 2,5-DICYANO-3,6-DIHALOGENOPYRAZINE KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10399960-B2 Dicyanopyrazine compound, luminescent material, luminescence device using the same, and method for producing 2,5-dicyano-3,6-dihalogenopyrazine DDT, HDHD5, F3 HPGD 649/4885USP8 3574/4885USP7 1377/4885
US-20190169170-A1 DICYANOPYRAZINE COMPOUND, LUMINESCENT MATERIAL, LUMINESCENCE DEVICE USING THE SAME, AND METHOD FOR PRODUCING 2,5-DICYANO-3,6-DIHALOGENOPYRAZINE DDT, HDHD5, F3 HPGD 649/4885USP8 3574/4885USP7 1377/4885
US-20190229274-A1 DICYANOPYRAZINE COMPOUND, LUMINESCENT MATERIAL, LUMINESCENCE DEVICE USING THE SAME, AND METHOD FOR PRODUCING 2,5-DICYANO-3,6-DIHALOGENOPYRAZINE DDT, NDUFS5, SDHA HPGD 605/4885USP8 3710/4885USP7 1449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.